Advertisements
Feeds:
Posts
Comments

Posts Tagged ‘Cancer Care’


Role of Informatics in Precision Medicine: Notes from Boston Healthcare Webinar: Can It Drive the Next Cost Efficiencies in Oncology Care?

Reporter: Stephen J. Williams, Ph.D.

Boston Healthcare sponsored a Webinar recently entitled ” Role of Informatics in Precision Medicine: Implications for Innovators”.  The webinar focused on the different informatic needs along the Oncology Care value chain from drug discovery through clinicians, C-suite executives and payers. The presentation, by Joseph Ferrara and Mark Girardi, discussed the specific informatics needs and deficiencies experienced by all players in oncology care and how innovators in this space could create value. The final part of the webinar discussed artificial intelligence and the role in cancer informatics.

 

Below is the mp4 video and audio for this webinar.  Notes on each of the slides with a few representative slides are also given below:

Please click below for the mp4 of the webinar:

 

 


  • worldwide oncology related care to increase by 40% in 2020
  • big movement to participatory care: moving decision making to the patient. Need for information
  • cost components focused on clinical action
  • use informatics before clinical stage might add value to cost chain

 

 

 

 

Key unmet needs from perspectives of different players in oncology care where informatics may help in decision making

 

 

 

  1.   Needs of Clinicians

– informatic needs for clinical enrollment

– informatic needs for obtaining drug access/newer therapies

2.  Needs of C-suite/health system executives

– informatic needs to help focus of quality of care

– informatic needs to determine health outcomes/metrics

3.  Needs of Payers

– informatic needs to determine quality metrics and managing costs

– informatics needs to form guidelines

– informatics needs to determine if biomarkers are used consistently and properly

– population level data analytics

 

 

 

 

 

 

 

 

 

 

 

 

What are the kind of value innovations that tech entrepreneurs need to create in this space? Two areas/problems need to be solved.

  • innovations in data depth and breadth
  • need to aggregate information to inform intervention

Different players in value chains have different data needs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Data Depth: Cumulative Understanding of disease

Data Depth: Cumulative number of oncology transactions

  • technology innovators rely on LEGACY businesses (those that already have technology) and these LEGACY businesses either have data breath or data depth BUT NOT BOTH; (IS THIS WHERE THE GREATEST VALUE CAN BE INNOVATED?)
  • NEED to provide ACTIONABLE as well as PHENOTYPIC/GENOTYPIC DATA
  • data depth more important in clinical setting as it drives solutions and cost effective interventions.  For example Foundation Medicine, who supplies genotypic/phenotypic data for patient samples supplies high data depth
  • technologies are moving to data support
  • evidence will need to be tied to umbrella value propositions
  • Informatic solutions will have to prove outcome benefit

 

 

 

 

 

How will Machine Learning be involved in the healthcare value chain?

  • increased emphasis on real time datasets – CONSTANT UPDATES NEED TO OCCUR. THIS IS NOT HAPPENING BUT VALUED BY MANY PLAYERS IN THIS SPACE
  • Interoperability of DATABASES Important!  Many Players in this space don’t understand the complexities integrating these datasets

Other Articles on this topic of healthcare informatics, value based oncology, and healthcare IT on this OPEN ACCESS JOURNAL include:

Centers for Medicare & Medicaid Services announced that the federal healthcare program will cover the costs of cancer gene tests that have been approved by the Food and Drug Administration

Broad Institute launches Merkin Institute for Transformative Technologies in Healthcare

HealthCare focused AI Startups from the 100 Companies Leading the Way in A.I. Globally

Paradoxical Findings in HealthCare Delivery and Outcomes: Economics in MEDICINE – Original Research by Anupam “Bapu” Jena, the Ruth L. Newhouse Associate Professor of Health Care Policy at HMS

Google & Digital Healthcare Technology

Can Blockchain Technology and Artificial Intelligence Cure What Ails Biomedical Research and Healthcare

The Future of Precision Cancer Medicine, Inaugural Symposium, MIT Center for Precision Cancer Medicine, December 13, 2018, 8AM-6PM, 50 Memorial Drive, Cambridge, MA

Live Conference Coverage @Medcity Converge 2018 Philadelphia: Oncology Value Based Care and Patient Management

2016 BioIT World: Track 5 – April 5 – 7, 2016 Bioinformatics Computational Resources and Tools to Turn Big Data into Smart Data

The Need for an Informatics Solution in Translational Medicine

 

 

 

 

Advertisements

Read Full Post »


Live Conference Coverage @Medcity Converge 2018 Philadelphia: Oncology Value Based Care and Patient Management

Reporter: Stephen J. Williams, Ph.D.

3:15 – 4:00 PM Breakout: What’s A Good Model for Value-Based Care in Oncology?

How do you implement a value-based care model in oncology? Medicare has created a bundled payment model in oncology and there are lessons to be learned from that and other programs. Listen to two presentations from experts in the field.

Moderator: Mahek Shah, M.D., Senior Researcher, Harvard Business School @Mahek_MD
Speakers:
Charles Saunders M.D., CEO, Integra Connect
Mari Vandenburgh, Director of Value-Based Reimbursement Operations, Highmark @Highmark

 

Mari: Building strategic partnerships with partners focused on population based health and evidence based outcomes. they provide data analytics and consultative services.  Incorporate risk based systems.  also looking at ancillary segments because they see cost savings.  True Performance is their flagship performance program and 11% lower ED (saving $18 million) rates and 16% lower readmissions ($200 million cost savings).  Also launched the Highmark Cancer care Program with Johns Hopkins.  They monitor the adherence pathways and if clinician shows good adherence they give reimbursements.

Charles:  Integra is a cloud based care platform focused on oncology and urology and allow clinicians to practice value based care. Providers must now focus on total cost including ER visits, end of life and therapies (which is half of total cost in US).  The actionable ways to reduce costs is by reducing ER visits.  What is working? Data on reimbursements models is very accurate so practices can dig into data and find effieciencies.  However most practices do not have the analytics to do this.

  • care navigation
  • care path based treatment choices
  • enhanced patient access and experience

What is not working

  • data not structured so someone has to do manual curation of records
  • flawed logic based on plurality of visits but physician doesn’t know who else they saw
  • target pricing not taking into account high prices of new therapies
  • lack of timely reporting either by patient or physician
  • insufficient reimbursements
  • technology limitations

 

4:10- 4:55 Breakout: What Patients Want and Need On Their Journey

Cancer patients are living with an existential threat every day. A panel of patients and experts in oncology care management will discuss what’s needed to make the journey for oncology patients a bit more bearable.

sponsored by CEO Council for Growth

Moderator: Amanda Woodworth, M.D., Director of Breast Health, Drexel University College of Medicine
Speakers:
Kezia Fitzgerald, Chief Innovation Officer & Co-Founder, CareAline® Products, LLC
Sara Hayes, Senior Director of Community Development, Health Union @SaraHayes_HU
Katrece Nolen, Cancer Survivor and Founder, Find Cancer Help @KatreceNolen
John Simpkins, Administrative DirectorService Line Director of the Cancer Center, Children’s Hospital of Philadelphia @ChildrensPhila

 

Kezia: was a cancer patient as well as her child getting treated at two different places and tough part was coordinating everything including treatments and schedules, working schedules

Katrece: had problem scheduling with oncologists because misdiagnosis and her imaging records were on CD and surgeon could not use the CD

John:  the above are a common frustration among patients at a time when they don’t need the confusion. He feels cancer centers need to coordinate these services better

Sara:  trying to assist people with this type of coordination is very tough even with all the resources

Kazia:  she needed to do all the research on her own because big dichotomy being an adult and a pediatric patient where pediatrics get more information and patient centered care. She felt she felt burdening the physicians if she asked the same questions.  How can we get more interaction with primary care physicians and feel comfortable with their interaction?

John: there is this dichotomy especially on wait times for adults is usually longer.  We can also improve patient experience with counseling patients

Katrece: Just working with a patient navigator is not enough.  The patient needs to take charge of their disease.

Sara: Patient communities can help as sometimes patients learn from other patients.

Amanda:  in breast cancer , navigators are common but must take care they are not only people patients see after a while

John:  at CHOP they also have a financial navigator.  On the adult side there are on call financial navigators.  Recent change of the high deductible plans are a major problem.  Although new families are starting to become comfortable with the financial navigator

Katrece:  guiding your children through your experience is important.  It was also important for her to advocate for herself as she had three different sites of cancer care to coordinate and multiple teams to coordinate with each other

Amanda:  A common theme seems to be hard trying to find the resources you need.  Why is that?

Kazia:  Sometimes it is hard to talk about your disease because it can be emotionally draining comforting other people who you told about the disease and they are being empathetic.  Sometimes they want to keep their ‘journey’ to themselves

John:  A relative kept her disease secret because she didn’t want to burden others…. a common cancer patient concern

Sara: Moderation of a social group is necessary to keep it a safe space and prevent trollers (like in Facebook support groups).

Kazia:  most group members will get together and force those trollers out of the group

Katrece: alot of anxiety after treatment ends, patient feels like being dropped on the floor like they don’t get support after treatment.  If there were survivorship navigators might be helpful

Amanda: for breast cancer they do a Survivor Care Package but just a paper packet, patients do appreciate it but a human coordinator would be a great idea

 

 

 

 

Please follow on Twitter using the following #hashtags and @pharma_BI

#MCConverge

#cancertreatment

#healthIT

#innovation

#precisionmedicine

#healthcaremodels

#personalizedmedicine

#healthcaredata

And at the following handles:

@pharma_BI

@medcitynews

 

Please see related articles on Live Coverage of Previous Meetings on this Open Access Journal

LIVE – Real Time – 16th Annual Cancer Research Symposium, Koch Institute, Friday, June 16, 9AM – 5PM, Kresge Auditorium, MIT

Real Time Coverage and eProceedings of Presentations on 11/16 – 11/17, 2016, The 12th Annual Personalized Medicine Conference, HARVARD MEDICAL SCHOOL, Joseph B. Martin Conference Center, 77 Avenue Louis Pasteur, Boston

Tweets Impression Analytics, Re-Tweets, Tweets and Likes by @AVIVA1950 and @pharma_BI for 2018 BioIT, Boston, 5/15 – 5/17, 2018

BIO 2018! June 4-7, 2018 at Boston Convention & Exhibition Center

https://pharmaceuticalintelligence.com/press-coverage/

 

Read Full Post »


LIVE Tweets via @pharma_BI and by @AVIVA1950 of 2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

Curator: Aviva Lev-Ari, PhD, RN

 

@pharma_BI

 

  1. @pharma_BI‏@Pharma_BI 18m18 minutes ago

Real Time Coverage and eProceedings of 2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel,…https://lnkd.in/essEc5p 

 

  1. @pharma_BI‏@Pharma_BI 33m33 minutes ago

Real Time Coverage and eProceedings of 2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin… https://pharmaceuticalintelligence.com/2016/04/28/real-time-

 

  1. @pharma_BI Retweeted

Aviva Lev-Ari ‏@AVIVA1950  8h8 hours ago

Have BIG idea for cancer care? @AstellasUS is looking for brilliance! Submit to http://www.C3Prize.com  #C3Prize VIA @Pharma_BI @AVIVA1950

1 retweet1 like

 

  1. @pharma_BI‏@Pharma_BI 8h8 hours ago

Innovation Break: Announcing the C³ Prize from Astellas Oncology and the World Medical Innovation Forum https://lnkd.in/eem9XRB 

 

 

  1. @pharma_BI Retweeted

Nature News&Comment ‏@NatureNews  16h16 hours ago

Biden time: The US vice-president’s cancer project is winning hearts and minds http://bit.ly/1SL0u8c 

 

  1. @pharma_BI‏@Pharma_BI Apr 27

Top Three among Disruptive Dozen Technologies: The Future of Cancer Therapies @2016 World Medical Innovation Forum https://lnkd.in/eyuJfS8 

 

  1. @pharma_BI‏@Pharma_BI Apr 27

Top Three among Disruptive Dozen Technologies: The Future of Cancer Therapies @2016 World Medical Innovation Forum https://pharmaceuticalintelligence.com/2016/04/27/top-three-among-disruptive-dozen-technologies-the-future-of-cancer-therapies-2016-world-medical-innovation-forum/ …

 

  1. @pharma_BI‏@Pharma_BI Apr 27

CRISPR: Genome Editing and Cancer was ranked 7th on the List of Disruptive Dozen Technologies @2016 World Medical In…https://lnkd.in/ewe9Fyr 

 

  1. @pharma_BI‏@Pharma_BI Apr 27

CRISPR: Genome Editing and Cancer was ranked 7th on the List of Disruptive Dozen Technologies @2016 World Medical… https://pharmaceuticalintelligence.com/2016/04/27/crispr-genome-editing-and-cancer-was-ranked-7th-on-the-list-of-disruptive-dozen-technologies-2016-world-medical-innovation-forum/ …

 

  1. @pharma_BI‏@Pharma_BI  Apr 27

LIVE 11:25 am – 12:25 pm 4/27/2016 Disruptive Dozen Technologies: The Future of Cancer Therapies @2016 World Medical…https://lnkd.in/bnPVPG4 

 

  1. @pharma_BI‏@Pharma_BI  Apr 27

LIVE 11:25 am – 12:25 pm 4/27/2016 Disruptive Dozen Technologies: The Future of Cancer… https://pharmaceuticalintelligence.com/2016/04/27/live-1125-am-1225-pm-4272016-

 

  1. @pharma_BI‏@Pharma_BI  Apr 27

LIVE 8:10 am – 11:20 am 4/27/2016 Combination Cancer Therapies: Drug Resistance and Therapeutic Index & Cancer Diagn…https://lnkd.in/eVrk3RF 

  1. @pharma_BI‏@Pharma_BI  Apr 27

LIVE 8:10 am – 11:20 am 4/27/2016 Combination Cancer Therapies: Drug Resistance and… https://pharmaceuticalintelligence.com/2016/04/27/live-810-am-1120-am-4272016-

 

  1. @pharma_BI‏@Pharma_BI  Apr 27

4:00 pm – 4:50 pm 4/26/2016 Arms Race in Radiation & Breakthrough Devices to Treat Cancer… https://pharmaceuticalintelligence.com/2016/04/27/400-pm-

 

  1. @pharma_BI Retweeted

Bristol-Myers Squibb ‏@bmsnews  Apr 26

CEO Giovanni Caforio now live on @CNBC discussing our commitment to develop transformational medicines. #WFIM16

 

  1. @pharma_BI Retweeted

Novartis ‏@Novartis  Apr 26

Decades of immune research now potentially applies to the cancer problem— Glenn Dranoff @NovartisScience #WMIF16

 

  1. @pharma_BI Retweeted

 

  1. @pharma_BI‏@Pharma_BI  Apr 26

LIVE 4:00 pm – 4:50 pm 4/26/2016 Study Designs to Meet the Challenges of Personalized Cancer Medicine & Surviving Ca…https://lnkd.in/eHBRG7d 

 

  1. @pharma_BI‏@Pharma_BI  Apr 26

LIVE 4:00 pm – 4:50 pm 4/26/2016 Study Designs to Meet the Challenges of Personalized…

 

  1. @pharma_BI‏@Pharma_BI  Apr 26

LIVE 1:40 pm – 3:50 pm 4/26/2016 Fireside Chat: Patients Driving Innovation & Immunotherapy II: Cell Based Therapies…https://lnkd.in/eYjHPNH 

 

  1. @pharma_BI‏@Pharma_BI  Apr 26

LIVE 1:40 pm – 3:50 pm 4/26/2016 Fireside Chat: Patients Driving Innovation & Immunotherapy… https://pharmaceuticalintelligence.com/2016/04/26/live-140-pm-350-pm-4262016-

 

@pharma_BI ‏@Pharma_BI  Apr 26

LIVE 12:30 pm – 1:30 pm 4/26/2016 Fireside Chats: Andy Slavitt, Acting Administrator, CMS & Giovanni Caforio, MD, CE…https://lnkd.in/ecXjfVU 

 

  1. @pharma_BI‏@Pharma_BI  Apr 26

LIVE 12:30 pm – 1:30 pm 4/26/2016 Fireside Chats: Andy Slavitt, Acting Administrator, CMS &… https://pharmaceuticalintelligence.com/2016/04/26/live-1230-pm-130-pm-4262016-

 

@pharma_BI ‏@Pharma_BI  Apr 26

LIVE 10:25 am – 12:00 pm 4/26/2016 Fireside Chat: Robert Bradway, CEO, Amgen & Immunotherapy I: Checkpoint Activatio…https://lnkd.in/eD25Pr6 

 

  1. @pharma_BI‏@Pharma_BI  Apr 26

LIVE 10:25 am – 12:00 pm 4/26/2016… https://pharmaceuticalintelligence.com/2016/04/26/live-1025-am-1200-pm-4262016-

 

  1. @pharma_BI‏@Pharma_BI  Apr 26

LIVE 8:15 am – 9:55 am 4/26/2016 Global Cancer Markets & Epigenetics and Novel Cancer Targets @2016 World Medical In…https://lnkd.in/eWJpuxE 

 

  1. @pharma_BI‏@Pharma_BI  Apr 26

LIVE 8:15 am – 9:55 am 4/26/2016… https://pharmaceuticalintelligence.com/2016/04/26/live-815-am-955-am-4262016-

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE 4:50 pm – 5:55 pm 4/25/2016 Early Detection and Prevention of Cancer & Innovation Break: Announcing the C³ Priz…https://lnkd.in/eh6a42e 

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

Innovation Break: Announcing the C³ Prize from Astellas Oncology and the World Medical Innovation Forum https://lnkd.in/eem9XRB 

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

Innovation Break: Announcing the C³ Prize from Astellas Oncology and the World Medical Innovation Forum https://pharmaceuticalintelligence.com/2016/04/25/innovation-break-announcing-the-c%c2%b3-prize-from-astellas-oncology-and-the-world-medical-innovation-forum …

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE 4:50 pm – 5:55 pm 4/25/2016 Early Detection and Prevention of Cancer & Innovation… https://pharmaceuticalintelligence.com/2016/04/25/live-450-pm-555-pm-4252016-

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE 4:00 pm – 4:50 pm 4/25/2016 Winning Portfolio Strategy @2016 World Medical Innovation Forum: CANCER, April 25-2…https://lnkd.in/euJGZsR 

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE 4:00 pm – 4:50 pm 4/25/2016 Winning Portfolio Strategy @2016 World Medical Innovation… https://pharmaceuticalintelligence.com/2016/04/25/live-400-pm-450-pm-4252016-

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE 3:10 pm – 4:00 pm 4/25/2016 3:10 pm – 4:00 pm Curative Therapies: The Economics of Game Changing Science @2016https://lnkd.in/e6a8Hed 

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE 3:10 pm – 4:00 pm 4/25/2016 3:10 pm – 4:00 pm Curative Therapies: The Economics of… https://pharmaceuticalintelligence.com/2016/04/25/live-310-pm-400-pm-4252016-

 

@pharma_BI ‏@Pharma_BI  Apr 25

LIVE 1:45 pm – 3:10 pm 4/25/2016 Forum Opening, A War or Moonshot: Where Do We Stand? Creating a Disruptive Cancer P…https://lnkd.in/eWX42-5 

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE 1:45 pm – 3:10 pm 4/25/2016 Forum Opening, A War or Moonshot: Where Do We Stand?… https://pharmaceuticalintelligence.com/2016/04/25/live-145-pm-310-pm-4252016-

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE Look: The Next Wave of Cancer Breakthroughs @2016 World … @ Partners16 https://pharmaceuticalintelligence.com/2016/04/25/live-800-am-1200-pm-4252016-first-look-the-next-wave-of-cancer-breakthroughs-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/ … via @Pharma_BI

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

12:00 pm – 1:30 pm 4/25/2016, Discovery Café: Enjoy Lunch with Top Cancer Leadership from across Partners HealthCare…https://lnkd.in/evvmf85 

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

12:00 pm – 1:30 pm 4/25/2016, Discovery Café: Enjoy Lunch with Top Cancer Leadership from… https://pharmaceuticalintelligence.com/2016/04/25/1200-

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE – 8:00 am – 12:00 pm 4/25/2016 – First Look: The Next Wave of Cancer Breakthroughs @2016 World Medical Innovati…https://lnkd.in/ehvWkKE 

 

  1. @pharma_BI‏@Pharma_BI  Apr 25

LIVE – 8:00 am – 12:00 pm 4/25/2016 – First Look: The Next Wave of Cancer Breakthroughs… https://pharmaceuticalintelligence.com/2016/04/25/live-800-am-1200-pm-4252016-

@AVIVA1950

    1. Aviva Lev-Ari‏@AVIVA1950  8m8 minutes ago

#WMIF16 @PartnersWMIF Real Time Coverage and eProceedings: 2016 WMIF CANCER, April 25-27, 201… https://pharmaceuticalintelligence.com/2016/04/28/real-time-coverage-and-eproceedings-of-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/ … @Pharma_BI@AVIVA1950

 

    1. Aviva Lev-Ari‏@AVIVA1950  12m12 minutes ago

Real Time Coverage and eProceedings of 2016 World Medical Innovation Forum: CANCER, April 25-27, 201… https://pharmaceuticalintelligence.com/2016/04/28/real-time-coverage-and-eproceedings-of-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/ … via @Pharma_BI

 

  1. Aviva Lev-Ari‏@AVIVA1950  7h7 hours ago

Have BIG idea for cancer care? @AstellasUS is looking for brilliance! Submit to http://www.C3Prize.com  #C3Prize VIA @Pharma_BI @AVIVA1950

 

  1. Aviva Lev-Ari‏@AVIVA1950  8h8 hours ago

Have an innovative idea for cancer care? @AstellasUS is looking for brilliance! Submit to http://www.C3Prize.com  #C3Prize

 

  1. Aviva Lev-Ari‏@AVIVA1950  8h8 hours ago

Have BIG idea for cancer care? @AstellasUS is looking for brilliance! Submit to http://www.C3Prize.com  #C3Prize VIA pharma_BI @AVIVA1950

 

  1. Aviva Lev-Ari‏@AVIVA1950  8h8 hours ago

innovative idea for cancer care? @AstellasUS is looking for brilliance! Submit to http://www.C3Prize.com  #C3Prize @pharma_BI @AVIVA1950

0 retweets1 like

 

  1. Aviva Lev-Ari‏@AVIVA1950  8h8 hours ago

innovative idea for cancer care? @AstellasUS is looking for brilliance! Submit to http://www.C3Prize.com  #C3Prize via @Pharma_BI @AVIVA1950

 

    1. Aviva Lev-Ari‏@AVIVA1950  8h8 hours ago

Innovation Break: Announcing the C³ Prize from Astellas Oncology and the World Medical Innovation Fo… https://pharmaceuticalintelligence.com/2016/04/25/innovation-break-announcing-the-c%c2%b3-prize-from-astellas-oncology-and-the-world-medical-innovation-forum/ … via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  17h17 hours ago

CMS releases MACRA rule proposal #WMIF16 @Partners2016 @AVIVA1950 @pharma_BI

 

World Forum @PartnersWMIF Thanks to @AVIVA1950 @SaudeemFoco for tweeting throughout #WMIF16! Efforts much appreciated.

 

World Forum ‏@PartnersWMIF  Apr 27

Thanks to @lisamjarvis @scchak @jaimy_lee @mo_brouillette @AVIVA1950 @SaudeemFoco for tweeting throughout #WMIF16! Efforts much appreciated.

1 retweet 5 likes

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 27

#WMIF16 Top Three among Disruptive Dozen Technologies: Cancer Therapies @2016 World Medical In… https://pharmaceuticalintelligence.com/2016/04/27/top-three-among-disruptive-dozen-technologies-the-future-of-cancer-therapies-2016-world-medical-innovation-forum/ … via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 27

Top Three among Disruptive Dozen Technologies: The Future of Cancer Therapies @2016 World Medical In… https://pharmaceuticalintelligence.com/2016/04/27/top-three-among-disruptive-dozen-technologies-the-future-of-cancer-therapies-2016-world-medical-innovation-forum/ … via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 27

#WMIF16 CRISPR: Genome Editing and Cancer 7th on the List of Disruptive Dozen Technologies @2016https://pharmaceuticalintelligence.com/2016/04/27/crispr-genome-editing-and-cancer-was-ranked-7th-on-the-list-of-disruptive-dozen-technologies-2016-world-medical-innovation-forum/ … via @Pharma_BI

More

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 27

CRISPR: Genome Editing and Cancer was ranked 7th on the List of Disruptive Dozen Technologies @2016https://pharmaceuticalintelligence.com/2016/04/27/crispr-genome-editing-and-cancer-was-ranked-7th-on-the-list-of-disruptive-dozen-technologies-2016-world-medical-innovation-forum/ … via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 27

LIVE 11:25 am – 12:25 pm 4/27/2016 Disruptive Dozen Technologies: The Future of Cancer Therapies @20https://pharmaceuticalintelligence.com/?p=40798  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 27

#WMIF16 @PartnersWMIF Combination Cancer Therapies: Drug Resistance and Therapeutic Inde… https://pharmaceuticalintelligence.com/?p=40796  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 27

LIVE 8:10 am – 11:20 am 4/27/2016 Combination Cancer Therapies: Drug Resistance and Therapeutic Inde… https://pharmaceuticalintelligence.com/?p=40796  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 27

New e-Book TITLES forthcoming, http://Amazon.com  in 2016 LPBI Group’s BioMed e-Series – Forthc… https://pharmaceuticalintelligence.com/?p=41309  via @pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE #WMIF16 Andy Slavitt, Acting Administrator, CMS & Giovanni… https://pharmaceuticalintelligence.com/?p=40788  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

Study Designs: Challenges of Personalized Cancer Medicin… https://pharmaceuticalintelligence.com/?p=40794  via @Pharma_BI @PartnersWMIF #WMIF16 @Partners2016

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 4:00 pm – 4:50 pm 4/26/2016 Study Designs to Meet the Challenges of Personalized Cancer Medicin… https://pharmaceuticalintelligence.com/?p=40794  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

C³ Prize from Astellas Oncology and the World Medical Innovation Fo…@PartnersWMIF @Partners2016 https://pharmaceuticalintelligence.com/?p=41797  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 4/26/2016 Global Cancer Markets & Epigenetics and Novel Cancer Targets @2016@Partners2016 https://pharmaceuticalintelligence.com/?p=40784  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 10:25 am – 12:00 pm 4/26/2016 Robert Bradway, CEO, Amgen & Immunotherapy I: Che @Partners2016https://pharmaceuticalintelligence.com/?p=40786  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 12:30 pm – 1:30 pm 4/26/2016 Andy Slavitt, CMS & Giovanni… @Partners2016 https://pharmaceuticalintelligence.com/?p=40788  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 4/26/2016 Immunotherapy II: Cell…@PartnersWMIF16 #WMIF16 @Partners2016 https://pharmaceuticalintelligence.com/?p=40790  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 1:40 pm – 3:50 pm 4/26/2016 Fireside Chat: Patients Driving Innovation & Immunotherapy II: Cell… https://pharmaceuticalintelligence.com/?p=40790  via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

@PartnersWMIF16 #WMIF16 @Paertners2016 https://pharmaceuticalintelligence.com/2016/04/26/live-1230-pm-130-pm-4262016-fireside-chats-andy-slavitt-acting-administrator-cms-giovanni-caforio-md-ceo-bristol-myers-squibb-2016-world-medical-innovation-forum-cancer-april-25-2/ … via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

CMS & BMS @PartnersWMIF16 #WMIF16 @Paertners2016 https://pharmaceuticalintelligence.com/2016/04/26/live-1230-pm-130-pm-4262016-fireside-chats-andy-slavitt-acting-administrator-cms-giovanni-caforio-md-ceo-bristol-myers-squibb-2016-world-medical-innovation-forum-cancer-april-25-2/ … via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 12:30 pm – 1:30 pm 4/26/2016 Fireside Chats: Andy Slavitt, Acting Administrator, CMS & Giovanni… https://pharmaceuticalintelligence.com/2016/04/26/live-1230-pm-130-pm-4262016-fireside-chats-andy-slavitt-acting-administrator-cms-giovanni-caforio-md-ceo-bristol-myers-squibb-2016-world-medical-innovation-forum-cancer-april-25-2/ … via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 4/26/2016 CEO, Amgen & Immunotherapy I: Che…@PartnersWMIF16 #WMIF16 @Paertners2016 https://pharmaceuticalintelligence.com/2016/04/26/live-1025-am-1200-pm-4262016-fireside-chat-robert-bradway-ceo-amgen-immunotherapy-i-checkpoint-activation-and-cancer-vaccines-2016-world-medical-innovation-forum-cancer-april-25-27/ … via @Pharma_BI

 

  1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 10:25 am – 12:00 pm 4/26/2016 Fireside Chat: Robert Bradway, CEO, Amgen & Immunotherapy I: Che… https://pharmaceuticalintelligence.com/2016/04/26/live-1025-am-1200-pm-4262016-fireside-chat-robert-bradway-ceo-amgen-immunotherapy-i-checkpoint-activation-and-cancer-vaccines-2016-world-medical-innovation-forum-cancer-april-25-27/ … via @Pharma_BI

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 4/26/2016 Epigenetics and Novel Cancer Targets @PartnersWMIF16 #WMIF16 @Paertners2016… https://pharmaceuticalintelligence.com/2016/04/26/live-815-am-955-am-4262016-global-cancer-markets-epigenetics-and-novel-cancer-targets-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/ … via @wordpressdotcom

 

    1. Aviva Lev-Ari‏@AVIVA1950  Apr 26

LIVE 8:15 am – 9:55 am 4/26/2016 Global Cancer Markets & Epigenetics and Novel Cancer Targets… https://pharmaceuticalintelligence.com/2016/04/26/live-815-am-955-am-4262016-global-cancer-markets-epigenetics-and-novel-cancer-targets-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/ … via @wordpressdotcom

Read Full Post »


Real Time Coverage and eProceedings of 2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

Curator: Aviva Lev-Ari, PhD, RN

Director & Founder

Leaders in Pharmaceutical Business Intelligence Group, Boston

Editor-in-Chief

http://pharmaceuticalintelligence.com

e-Mail: avivalev-ari@alum.berkeley.edu

SkypeID: HarpPlayer83 

LinkedIn Profile        Twitter Profile

 

LIVE – 8:00 am – 12:00 pm 4/25/2016 – First Look: The Next Wave of Cancer Breakthroughs @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/25/live-800-am-1200-pm-4252016-first-look-the-next-wave-of-cancer-breakthroughs-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/

 

12:00 pm – 1:30 pm 4/25/2016, Discovery Café: Enjoy Lunch with Top Cancer Leadership from across Partners HealthCare @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/25/1200-pm-130-pm-4252016-discovery-cafe-enjoy-lunch-with-top-cancer-leadership-from-across-partners-healthcare-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-bost/

 

LIVE 1:45 pm – 3:10 pm 4/25/2016 Forum Opening, A War or Moonshot: Where Do We Stand? Creating a Disruptive Cancer Pipeline @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/25/live-145-pm-310-pm-4252016-forum-opening-a-war-or-moonshot-where-do-we-stand-creating-a-disruptive-cancer-pipeline-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hote/

 

LIVE 3:10 pm – 4:00 pm 4/25/2016 3:10 pm – 4:00 pm Curative Therapies: The Economics of Game Changing Science @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/25/live-310-pm-400-pm-4252016-310-pm-400-pm-curative-therapies-the-economics-of-game-changing-science-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/

 

LIVE 4:00 pm – 4:50 pm 4/25/2016 Winning Portfolio Strategy @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/25/live-400-pm-450-pm-4252016-winning-portfolio-strategy-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/

 

LIVE 4:50 pm – 5:55 pm Early Detection and Prevention of Cancer & Innovation Break: Announcing the C³ Prize from Astellas Oncology and the World Medical Innovation Forum @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/25/live-450-pm-555-pm-4252016-early-detection-and-prevention-of-cancer-innovation-break-announcing-the-c%C2%B3-prize-from-astellas-oncology-and-the-world-medical-innovation-forum-2016-world/

 

Innovation Break: Announcing the C³ Prize from Astellas Oncology and the World Medical Innovation Forum

https://pharmaceuticalintelligence.com/2016/04/25/innovation-break-announcing-the-c%C2%B3-prize-from-astellas-oncology-and-the-world-medical-innovation-forum/

 

LIVE 8:15 am – 9:55 am 4/26/2016  Global Cancer Markets & Epigenetics and Novel Cancer Targets @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/26/live-815-am-955-am-4262016-global-cancer-markets-epigenetics-and-novel-cancer-targets-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/

 

LIVE 10:25 am – 12:00 pm 4/26/2016  Fireside Chat: Robert Bradway, CEO, Amgen & Immunotherapy I: Checkpoint Activation and Cancer Vaccines @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/26/live-1025-am-1200-pm-4262016-fireside-chat-robert-bradway-ceo-amgen-immunotherapy-i-checkpoint-activation-and-cancer-vaccines-2016-world-medical-innovation-forum-cancer-april-25-27/

 

LIVE 12:30 pm – 1:30 pm 4/26/2016 Fireside Chats: Andy Slavitt, Acting Administrator, CMS & Giovanni Caforio, MD, CEO, Bristol-Myers Squibb @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/26/live-1230-pm-130-pm-4262016-fireside-chats-andy-slavitt-acting-administrator-cms-giovanni-caforio-md-ceo-bristol-myers-squibb-2016-world-medical-innovation-forum-cancer-april-25-2/

 

LIVE 1:40 pm – 3:50 pm 4/26/2016 Fireside Chat: Patients Driving Innovation & Immunotherapy II: Cell Based Therapies & Financing Breakthrough Cancer Companies @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/26/live-140-pm-350-pm-4262016-fireside-chat-patients-driving-innovation-immunotherapy-ii-cell-based-therapies-financing-breakthrough-cancer-companies-2016-world-medical-innovation-fo/

 

LIVE 4:00 pm – 4:50 pm 4/26/2016 Study Designs to Meet the Challenges of Personalized Cancer Medicine & Surviving Cancer: New Realities, New Needs @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/26/live-400-pm-450-pm-4262016-study-designs-to-meet-the-challenges-of-personalized-cancer-medicine-surviving-cancer-new-realities-new-needs-2016-world-medical-innovation-forum-cancer-apr/

 

LIVE 8:10 am – 11:20 am 4/27/2016 Combination Cancer Therapies: Drug Resistance and Therapeutic Index & Cancer Diagnostics: New Uses, New Reimbursements? & New Philanthropy: Patients Driving Innovation@2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/27/live-810-am-1120-am-4272016-combination-cancer-therapies-drug-resistance-and-therapeutic-index-cancer-diagnostics-new-uses-new-reimbursements-new-philanthropy-patients-driving-i/

 

LIVE 11:25 am – 12:25 pm 4/27/2016 Disruptive Dozen Technologies: The Future of Cancer Therapies @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/04/27/live-1125-am-1225-pm-4272016-disruptive-dozen-technologies-the-future-of-cancer-therapies-2016-world-medical-innovation-forum-cancer-april-25-27-2016-westin-hotel-boston/

 

CRISPR: Genome Editing and Cancer was ranked 7th on the List of Disruptive Dozen Technologies @2016 World Medical Innovation Forum

https://pharmaceuticalintelligence.com/2016/04/27/crispr-genome-editing-and-cancer-was-ranked-7th-on-the-list-of-disruptive-dozen-technologies-2016-world-medical-innovation-forum/

 

Top Three among Disruptive Dozen Technologies: The Future of Cancer Therapies @2016 World Medical Innovation Forum

https://pharmaceuticalintelligence.com/2016/04/27/top-three-among-disruptive-dozen-technologies-the-future-of-cancer-therapies-2016-world-medical-innovation-forum/

 

Read Full Post »